IDXX vs NDAQ · P/E 40, rev $2.36B vs P/E 41, rev $2.53B
IDEXX Laboratories Inc (IDXX) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the IDXX and NDAQ stock pages for the full models.
Not investment advice.